Urinary tract obstruction occurs when the normal flow of urine from the bladder is partially or completely blocked. Urinary tract obstruction treatment devices help restore normal urine flow from the bladder. The growing prevalence of urinary tract disorders such as benign prostatic hyperplasia (BPH), urinary tract stones, and other conditions are driving the demand for urinary tract obstruction treatment devices.
The Global Urinary Tract Obstruction Treatment Devices Market is estimated to be valued at USD 1.41 billion in 2024 and is expected to reach USD 2.03 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.2% from 2024 to 2031.
Key TakeawaysKey players operating in the urinary tract obstruction treatment devices are Boston Scientific Corporation, Cook Medical, Olympus Corporation, CL Medical, and Coloplast.
These players focus on new product launches and acquisitions to strengthen their market position.There is high growth potential in emerging economies owing to increasing healthcare investments and rising medical tourism. Growing awareness about Urinary Tract Obstruction Treatment Devices Market and availability of various treatment options present significant opportunities in the market.Major players are expanding their operations in Asia Pacific and Latin America through strategic collaborations with local players to tap the high growth opportunities in these regions.
Market driversThe growing geriatric population worldwide is a key driver for the market as BPH and urinary stones are more common in the elderly. According to WHO, the number of people aged 65 years and above is expected to reach 1.5 billion by 2050 from 703 million in 2019. Moreover, rising lifestyle diseases like obesity and diabetes that increase the risk of urinary tract disorders will further fuel market growth over the coming years.
PEST Analysis
Political: Regulations around medical device approval have been increasing stringency over time to ensure patient safety. This can sometimes slow market growth rates.
Economic: Overall healthcare spending is expected to continue increasing which provides opportunities for growth, though individual device markets may see fluctuations depending on cost and reimbursement factors.
Social: An aging population profile means prevalence of conditions treated by these devices will rise in many nations. As life expectancies increase, demand for related products and services grows.
Technological: Advancements in materials and minimally invasive procedures allow for less risk, faster recovery times and more options for patients and physicians. Growth opportunities emerge with novel technologies that improve clinical outcomes.
Geographical concentrationThe United States market currently represents the largest share of the global urinary tract obstruction treatment devices market in terms of value, given the size of the country's healthcare market and spending. However, growth rates are likely to be higher in emerging Asian countries.
Fastest growing regionsThe Asia Pacific region is anticipated to experience the fastest growth in the urinary tract obstruction treatment devices market over the coming years. This is due to growing healthcare infrastructure and spending power, paired with a large patient population in nations such as China and India where increased prevalence of associated diseases is also a factor driving market expansion.
Get this Report in Japanese Language: 尿路閉塞治療機器市場
Get this Report in Korean Language: 요로폐쇄 치료 장치 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)
The Urinary Tract Infection Treatment Market research report provides the latest industry data, growth, key segments and future trends on the basis of the detailed study.
This market report also allows you to identify the future opportunity and growth rate of the leading segment based on regions and countries.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the urinary tract infection treatment market include AstraZeneca, Bayer AG, Cipla, Inc., GlaxoSmithKline PLC, MerlionPharma, Novartis AG and Pfizer.
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Urinary Tract Infection Treatment Market Research Report" by requesting FREE Sample Copy athttps://www.valuemarketresearch.com/contact/urinary-tract-infection-treatment-market/download-sampleMarket DynamicsThe increasing prevalence of diabetes and kidney stones is primarily driving the market growth.
However, lack of awareness in developing and underdeveloped economies is likely to hamper the market growth.
Whereas, the increasing recurrence rate for UTIs is expected to augment the demand for treatment over the forecast period.The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis.
